Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Preclinical proof-of-concept study in cell culture and animal models demonstrating a novel composite material's ability to modulate the tumor microenvironment and enhance immune engagement; no human data or clinical endpoints reported.
Mechanistic discovery in human and mouse lung tissue identifying a previously unrecognized TRM subset and its role in heterologous protection, but lacks clinical endpoint data or human efficacy demonstration.